SmithKline Beecham
14
0
0
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
36%
5 trials in Phase 3/4
15%
2 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Role: collaborator
TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma
Role: collaborator
A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum
Role: collaborator
Evaluation of Weekly Tafenoquine
Role: collaborator
An Evaluation of Weekly Tafenoquine
Role: collaborator
Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
Role: collaborator
Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes
Role: collaborator
Use of Topotecan in Patients With Refractory Acute Leukemia
Role: collaborator
Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer
Role: lead
A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide
Role: collaborator
Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment
Role: collaborator
Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients
Role: collaborator
A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
Role: lead
Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)
Role: lead
All 14 trials loaded